Control | Tamsulosin | Solifenacin | Combined therapy | P value | ||
---|---|---|---|---|---|---|
Age | Mean ± SD | 38 ± 7 | 39 ± 1 | 40 ± 4 | 39 ± 8 | 0.55 |
Sex: n (%) | Male | 21 (53.8) | 20 (58.8) | 19 (51.4) | 18 (54.4) | 0.37 |
Female | 18 (46.2) | 14 (41.2) | 18 (48.6) | 15 (45.6) | ||
Side: n (%) | Right | 19 (48.7) | 16 (47.1) | 21 (56.8) | 20 (60.6) | 0.09 |
Left | 20 (51.3) | 18 (52.9) | 16 (43.2) | 13 (39.4) | ||
Indications for stent fixation: n (%) | URS | 27 (69.2) | 22 (64.7) | 21(56.8) | 23 (69.7) | 0.64 |
ESWL | 8 (20.5) | 9 (26.5) | 11(29.7) | 7 (21.2) | ||
PNL | 4 (10.3) | 3 (8.8) | 5 (13.5) | 3 (9.1) | ||
Stone size (mm) In URS cases | Mean ± SD | 7.7 (1.9) | 7.4 (1.9) | 8.1 (2.2) | 7.8 (1.8) | 0.12 |